Kane Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.13M Sell
3,446
-43
-1% -$43.9K 1.76% 10
2026
Q1
$3.21M Sell
3,489
-230
-6% -$233K 1.65% 12
2025
Q4
$4M Sell
3,719
-28
-0.7% -$26.8K 1.94% 8
2025
Q3
$2.86M Sell
3,747
-6
-0.2% -$4.46K 1.39% 12
2025
Q2
$2.93M Sell
3,753
-483
-11% -$375K 1.54% 9
2025
Q1
$3.5M Buy
4,236
+218
+5% +$181K 1.69% 7
2024
Q4
$3.1M Buy
+4,018
New +$3.33M 1.73% 8

Other funds holding LLY

Kane Investment Management's LLY Position: Q2 2026 in Review

Kane Investment Management reduced its Eli Lilly (LLY) stake by 1.2% in Q2 2026, selling an estimated $43.9K and leaving 3,446 shares worth $4.13M. The position accounts for 1.76% of the portfolio, ranked #10.

Kane Investment Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kane Investment Management held 3,446 shares of Eli Lilly worth $4.13M as of Q2 2026.
  • Kane Investment Management sold 43 Eli Lilly shares in Q2 2026, an estimated $43.9K.
  • Eli Lilly made up 1.76% of Kane Investment Management's portfolio in Q2 2026, its #10 holding.
  • Kane Investment Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kane Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.